Total Payments
$17,905
2024 Payments
$2,088
Companies
55
Transactions
895
Medicare Patients
9,351
Medicare Billing
$2.0M
Payment Breakdown by Category
Food & Beverage$16,680 (93.2%)
Travel$872.93 (4.9%)
Education$352.06 (2.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,680 | 880 | 93.2% |
| Travel and Lodging | $872.93 | 7 | 4.9% |
| Education | $352.06 | 8 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,536 | 189 | $0 (2024) |
| Abbott Laboratories | $2,006 | 39 | $0 (2023) |
| Amgen Inc. | $1,733 | 101 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,041 | 29 | $0 (2023) |
| Impulse Dynamics (USA) Inc. | $847.99 | 37 | $0 (2024) |
| Tactile Systems Technology Inc | $814.39 | 64 | $0 (2023) |
| Boston Scientific Corporation | $737.29 | 14 | $0 (2024) |
| Cardiovascular Systems Inc. | $602.51 | 35 | $0 (2022) |
| PFIZER INC. | $522.78 | 50 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $488.92 | 35 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,088 | 90 | Novartis Pharmaceuticals Corporation ($447.29) |
| 2023 | $2,241 | 112 | Novartis Pharmaceuticals Corporation ($482.56) |
| 2022 | $2,623 | 152 | Impulse Dynamics (USA) Inc. ($644.19) |
| 2021 | $1,501 | 78 | Novartis Pharmaceuticals Corporation ($274.56) |
| 2020 | $1,909 | 86 | Amgen Inc. ($370.26) |
| 2019 | $2,170 | 104 | AstraZeneca Pharmaceuticals LP ($242.57) |
| 2018 | $2,914 | 124 | Abbott Laboratories ($1,228) |
| 2017 | $2,458 | 149 | The Spectranetics Corporation ($345.10) |
All Payment Transactions
895 individual payment records from CMS Open Payments — Page 1 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Boston Scientific Corporation | Varithena Administration Pack (Device) | Food and Beverage | In-kind items and services | $35.02 | General |
| Category: Varithena_PI | ||||||
| 12/23/2024 | Boston Scientific Corporation | Varithena Administration Pack (Device) | Food and Beverage | In-kind items and services | $35.02 | General |
| Category: Varithena_PI | ||||||
| 12/18/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $9.92 | General |
| Category: Cardiology | ||||||
| 12/17/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $9.04 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/11/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $161.20 | General |
| Category: General - Therapies_CRM | ||||||
| 11/22/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.43 | General |
| Category: Cardiovascular | ||||||
| 11/20/2024 | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA (Device) | Food and Beverage | In-kind items and services | $27.20 | General |
| Category: Transcatheter Heart Valves | ||||||
| 11/14/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $10.71 | General |
| Category: Cardiology | ||||||
| 11/13/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $8.56 | General |
| Category: Cardiology | ||||||
| 11/12/2024 | Recor Medical Inc | PARADISE RENAL DENERVATION SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $21.95 | General |
| Category: Endovascular | ||||||
| 11/11/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.82 | General |
| Category: Cardiovascular | ||||||
| 11/05/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $6.49 | General |
| Category: Cardiology | ||||||
| 11/04/2024 | AngioDynamics, Inc. | AURYON LASER SYSTEM 100-120 VAC (Device) | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: PAD | ||||||
| 10/29/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $12.47 | General |
| Category: Cardiology | ||||||
| 10/23/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $20.67 | General |
| 10/22/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $11.25 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/16/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $13.34 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/02/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: Cardiology | ||||||
| 10/01/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.53 | General |
| Category: Cardiovascular | ||||||
| 09/27/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $23.33 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/25/2024 | Recor Medical Inc | PARADISE RENAL DENERVATION SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $24.49 | General |
| Category: Endovascular | ||||||
| 09/24/2024 | Recor Medical Inc | PARADISE RENAL DENERVATION SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $13.32 | General |
| Category: Endovascular | ||||||
| 09/19/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $33.36 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/18/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $3.75 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 37 | 2,712 | 4,429 | $1.4M | $435,597 |
| 2022 | 30 | 2,163 | 3,472 | $1.3M | $412,762 |
| 2021 | 33 | 2,318 | 3,675 | $1.6M | $572,386 |
| 2020 | 30 | 2,158 | 3,432 | $1.5M | $539,174 |
Total Patients
9,351
Total Services
15,008
Medicare Billing
$2.0M
Procedure Codes
136
All Medicare Procedures & Services
136 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 571 | 1,223 | $262,134 | $109,009 | 41.6% |
| 36475 | Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | Office | 2023 | 34 | 63 | $295,470 | $49,629 | 16.8% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 121 | 121 | $117,587 | $40,908 | 34.8% |
| 36465 | Injection of chemical agent into single incompetent vein of leg using ultrasound guidance | Office | 2023 | 18 | 33 | $104,115 | $33,980 | 32.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 219 | 226 | $103,282 | $33,236 | 32.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 143 | 164 | $46,903 | $22,213 | 47.4% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 91 | 364 | $58,968 | $16,278 | 27.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 148 | 148 | $48,544 | $16,095 | 33.2% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 20 | 20 | $28,740 | $12,974 | 45.1% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 23 | 28 | $33,824 | $11,947 | 35.3% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 56 | 56 | $33,992 | $11,265 | 33.1% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 64 | 128 | $39,424 | $10,035 | 25.5% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Office | 2023 | 39 | 110 | $26,510 | $9,690 | 36.6% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 57 | 113 | $25,086 | $8,612 | 34.3% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 142 | 143 | $21,720 | $6,921 | 31.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 487 | 616 | $20,925 | $6,296 | 30.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 26 | 26 | $10,738 | $3,966 | 36.9% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 35 | 187 | $9,860 | $3,463 | 35.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 29 | 38 | $7,942 | $3,462 | 43.6% |
| 36471 | Injection of chemical agent into multiple incompetent veins of leg | Office | 2023 | 15 | 23 | $8,073 | $3,441 | 42.6% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 24 | 155 | $8,343 | $3,047 | 36.5% |
| 93459 | Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | Facility | 2023 | 11 | 11 | $7,568 | $2,428 | 32.1% |
| 10180 | Complex drainage of wound infection after surgery | Office | 2023 | 11 | 12 | $8,868 | $2,172 | 24.5% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 12 | 16 | $6,320 | $1,939 | 30.7% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 31 | 73 | $4,964 | $1,632 | 32.9% |
About Dr. Shakeel Khan, MD
Dr. Shakeel Khan, MD is a Cardiovascular Disease healthcare provider based in Glendale, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1366530800.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Shakeel Khan, MD has received a total of $17,905 in payments from pharmaceutical and medical device companies, with $2,088 received in 2024. These payments were reported across 895 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($16,680).
As a Medicare-enrolled provider, Khan has provided services to 9,351 Medicare beneficiaries, totaling 15,008 services with total Medicare billing of $2.0M. Data is available for 4 years (2020–2023), covering 136 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Nuclear Cardiology, Interventional Cardiology
- Location Glendale, AZ
- Active Since 10/10/2006
- Last Updated 08/24/2021
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1366530800
Products in Payments
- ENTRESTO (Drug) $1,534
- Repatha (Biological) $1,467
- LEQVIO (Drug) $1,001
- Occluders (Device) $924.04
- ELIQUIS (Drug) $825.16
- Optimizer (Device) $666.56
- FARXIGA (Drug) $499.59
- VERQUVO (Drug) $458.48
- Peripheral Orbital Atherectomy System (Device) $432.60
- FLEXITOUCH (Device) $410.53
- Flexitouch Plus (Device) $403.86
- XARELTO (Drug) $382.61
- CVX-300CVX-300P (Device) $345.10
- LifeVest (Device) $338.10
- BRILINTA (Drug) $313.51
- NORTHERA (Drug) $305.32
- Impella (Device) $291.63
- Corlanor (Drug) $266.81
- Carnation Ambulatory Monitor (Device) $245.00
- CVI INJECTOR (Device) $195.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Glendale
John Mckenzie, M.d, M.D
Cardiovascular Disease — Payments: $191,549
Cardiovascular Disease $191,549
Hugo Riffel Dalinger, Md, MD
Cardiovascular Disease — Payments: $150,245
Cardiovascular Disease $150,245
Harry Balian, M.d, M.D
Cardiovascular Disease — Payments: $133,783
Cardiovascular Disease $133,783
Truong Duong, Md, MD
Cardiovascular Disease — Payments: $109,744
Cardiovascular Disease $109,744
Dr. Amir Hedayati-Rad, M.d, M.D
Cardiovascular Disease — Payments: $94,643
Cardiovascular Disease $94,643
Dr. Gordi Khera, Md, MD
Cardiovascular Disease — Payments: $87,731
Cardiovascular Disease $87,731